Literature DB >> 12352004

Autonomic neuropathies.

Phillip A Low1.   

Abstract

PURPOSE OF REVIEW: To update recent advances in the pathogenesis, pathophysiology and treatment of some autonomic neuropathies. RECENT
FINDINGS: When evaluating a patient with subacute autonomic neuropathy, certain autoantibodies are important in diagnosis and may influence management. Ganglionic antibody may be pathogenetically important while the paraneoplastic antibodies alert the clinician to the presence of an occult neoplasm. Autonomic failure is an integral component of diabetic neuropathy. Sildenafil is safe and efficacious in treating erectile dysfunction in diabetic patients. Sympathetic cardiac hyperinnervation can occur concurrently with denervation in diabetic neuropathy The gene mutations for hereditary sensory and autonomic neuropathies I, III, and IV are now known and there is clear unmyelinated fiber loss. Additional options for treatment of orthostatic hypotension include erythropoietin and, surprisingly, water. Botulinum toxin is efficacious, at least for a time, for the treatment of palmar and axillary hyperhidrosis.
SUMMARY: Ganglionic antibody likely mediates autoimmune autonomic neuropathy. Sympathetic cardiac hyperinnervation can occur and could potentially cause arrhythmia and sudden death. Knowledge of gene mutations of hereditary sensory and autonomic neuropathies I, III and IV could lead to more secure diagnosis of the disorders. Effective treatment of essential hyperhidrosis with botulinum toxin injection has been demonstrated. It might be possible to improve treatment of orthostatic hypotension acutely with water imbibation and chronically with erythropoieting.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2002        PMID: 12352004     DOI: 10.1097/00019052-200210000-00011

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  10 in total

1.  Endovascular procedures for the treatment of autonomic dysfunction.

Authors:  Christopher Gibbons; William Cheshire; Alexandru Barboi; Benjamin Levine; Brian Olshansky; Laurence Kinsella; Victoria E Claydon; Craig Crandall; Gregory Fink; Michael Joyner; Vaughan Macefield; Lucy Norcliffe-Kaufmann; Roy Freeman; Satish Raj; Julian Stewart; Paola Sandroni; Horacio Kaufmann; Thomas Chelimsky
Journal:  Clin Auton Res       Date:  2013-11-01       Impact factor: 4.435

Review 2.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

3.  Cutaneous constitutive nitric oxide synthase activation in postural tachycardia syndrome with splanchnic hyperemia.

Authors:  Julian M Stewart; Abhinav Nafday; Anthony J Ocon; Courtney Terilli; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

Review 4.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  The sympathetic nervous system in development and disease.

Authors:  Emily Scott-Solomon; Erica Boehm; Rejji Kuruvilla
Journal:  Nat Rev Neurosci       Date:  2021-10-01       Impact factor: 34.870

6.  An autocrine Wnt5a-Ror signaling loop mediates sympathetic target innervation.

Authors:  Yun Kyoung Ryu; Sarah Ellen Collins; Hsin-Yi Henry Ho; Haiqing Zhao; Rejji Kuruvilla
Journal:  Dev Biol       Date:  2013-02-27       Impact factor: 3.582

7.  Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome.

Authors:  Andrew T Del Pozzi; Akash Pandey; Marvin S Medow; Zachary R Messer; Julian M Stewart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-30       Impact factor: 4.733

Review 8.  Assessment of cutaneous axon-reflex responses to evaluate functional integrity of autonomic small nerve fibers.

Authors:  Mido M Hijazi; Sylvia J Buchmann; Annahita Sedghi; Ben M Illigens; Heinz Reichmann; Gabriele Schackert; Timo Siepmann
Journal:  Neurol Sci       Date:  2020-03-03       Impact factor: 3.307

9.  Autonomic function tests: some clinical applications.

Authors:  Phillip A Low; Victoria A Tomalia; Ki-Jong Park
Journal:  J Clin Neurol       Date:  2013-01-03       Impact factor: 3.077

10.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.